While several compounds are promoted via social media claiming benefits of tissue repair, skin rejuvenation and anti-aging, we are particularly alarmed by the number of patients in our public multidisciplinary obesity clinic admitting to the use of unregulated products for weight loss, presumed to be pharmaceutical grade glucagon-like peptide-1 receptor agonists (GLP-1RA)
Among GLP-1 medications, liraglutide (Saxenda) with daily dosing may offer better tolerability for some patients
The companies also report patent infringement, but compounders, pointing to the FDA loophole for drugs in shortage, appear to have defeated that argument for now
GLP-1 Drugs Survey Report: What Employers Are and Arent Covering in 2026
The psychological transition By eight weeks, most people experience a fundamental shift in their relationship with food
Can You Really Lose 10 Pounds in 2 Weeks